175 related articles for article (PubMed ID: 20403998)
21. The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo.
Arber N; Lieberman D; Wang TC; Zhang R; Sands GH; Bertagnolli MM; Hawk ET; Eagle C; Coindreau J; Zauber A; Lanas A; Levin B
Clin Ther; 2012 Mar; 34(3):569-79. PubMed ID: 22386831
[TBL] [Abstract][Full Text] [Related]
22. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
[TBL] [Abstract][Full Text] [Related]
23. Statins and the colorectum: hope for chemoprevention?
Baron JA
Cancer Prev Res (Phila); 2010 May; 3(5):573-5. PubMed ID: 20403999
[TBL] [Abstract][Full Text] [Related]
24. Risks and benefits of celecoxib to prevent recurrent adenomas.
Psaty BM; Potter JD
N Engl J Med; 2006 Aug; 355(9):950-2. PubMed ID: 16943408
[No Abstract] [Full Text] [Related]
25. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention with special reference to inherited colorectal cancer.
Lynch PM
Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
28. Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH.
Wang J; Cho NL; Zauber AG; Hsu M; Dawson D; Srivastava A; Mitchell-Richards KA; Markowitz SD; Bertagnolli MM
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):728-736. PubMed ID: 29769213
[No Abstract] [Full Text] [Related]
29. Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention.
Feng GS; Ma JL; Wong BC; Zhang L; Liu WD; Pan KF; Shen L; Zhang XD; Li J; Xia HH; Li JY; Lam SK; You WC
World J Gastroenterol; 2008 Jul; 14(28):4535-9. PubMed ID: 18680235
[TBL] [Abstract][Full Text] [Related]
30. Statin use and site-specific risk of colorectal cancer in individuals with hypercholesterolemia from the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS).
Lee JW; You NY; Kim Y; Kim Y; Kim J; Kang HT
Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):701-709. PubMed ID: 31133496
[TBL] [Abstract][Full Text] [Related]
31. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
[TBL] [Abstract][Full Text] [Related]
32. The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Lynch PM; Ayers GD; Hawk E; Richmond E; Eagle C; Woloj M; Church J; Hasson H; Patterson S; Half E; Burke CA
Am J Gastroenterol; 2010 Jun; 105(6):1437-43. PubMed ID: 20234350
[TBL] [Abstract][Full Text] [Related]
33. Effect of statin therapy on colorectal cancer.
Bardou M; Barkun A; Martel M
Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
[TBL] [Abstract][Full Text] [Related]
34. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Chen YX; Gao QY; Zou TH; Wang BM; Liu SD; Sheng JQ; Ren JL; Zou XP; Liu ZJ; Song YY; Xiao B; Sun XM; Dou XT; Cao HL; Yang XN; Li N; Kang Q; Zhu W; Xu HZ; Chen HM; Cao XC; Fang JY
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):267-275. PubMed ID: 31926918
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer.
Squires H; Tappenden P; Cooper K; Carroll C; Logan R; Hind D
Clin Ther; 2011 Sep; 33(9):1289-305. PubMed ID: 21840057
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
[TBL] [Abstract][Full Text] [Related]
37. Patient preferences for the chemoprevention of colorectal cancer.
Hur C; Broughton DE; Kong CY; Ozanne EM; Richards EB; Truong T; Gazelle GS
Dig Dis Sci; 2009 Oct; 54(10):2207-14. PubMed ID: 19057995
[TBL] [Abstract][Full Text] [Related]
38. Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas".
Cen YY
Circulation; 2007 Mar; 115(12):e348; author reply e349. PubMed ID: 17389275
[No Abstract] [Full Text] [Related]
39. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
40. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
